The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tapil’skaya N.I.

Saint-Petersburg State Pediatric Medical University

Mironova A.V.

St. Petersburg State Pediatric Medical University of the Ministry of Healthcare of Russian Federation

Silaeva E.A.

Military Medical Academy named after S.M. Kirov of the Ministry of defense of Russian Federation

Shkarupa A.V.

Military Medical Academy named after S.M. Kirov of the Ministry of defense of Russian Federation

Glushakov R.I.

St. Petersburg State Pediatric Medical University of the Ministry of Healthcare of Russian Federation;
Military Medical Academy named after S.M. Kirov of the Ministry of defense of Russian Federation

Chronic pelvic pain syndrome in women: risk factors, differential diagnosis, treatment and prevention

Authors:

Tapil’skaya N.I., Mironova A.V., Silaeva E.A., Shkarupa A.V., Glushakov R.I.

More about the authors

Journal: Russian Journal of Human Reproduction. 2021;27(2): 56‑64

DOI: 10.17116/repro20212702156

Views: 5756

Downloaded: 322

Download PDF (RU)
Contact the author
Table of contents

CHRONIC PELVIC PAIN SYNDROME IN WOMEN: RISK FACTORS, DIFFERENTIAL DIAGNOSIS, TREATMENT AND PREVENTION
CHRONIC PELVIC PAIN SYNDROME IN WOMEN: RISK FACTORS, DIFFERENTIAL DIAGNOSIS, TREATMENT AND PREVENTION

To cite this article:

Tapil’skaya NI, Mironova AV, Silaeva EA, Shkarupa AV, Glushakov RI. Chronic pelvic pain syndrome in women: risk factors, differential diagnosis, treatment and prevention. Russian Journal of Human Reproduction. 2021;27(2):56‑64. (In Russ.)
https://doi.org/10.17116/repro20212702156

Подписка 2025-2 (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Analysis of the effe­ctiveness of various methods of mana­ging patients with endo­metriosis and justification for long-term personalized anti-relapse therapy with dydrogesterone as part of their combination treatment stra­tegy. Russian Journal of Human Reproduction. 2024;(2):102-111
Clinical and morphological asse­ssment of patients with adenomyosis: own data. Russian Journal of Human Reproduction. 2024;(2):130-135
Pathogenetic aspe­cts of chro­nic pelvic pain in endo­metriosis: diagnostic prospects (literature review). Russian Journal of Human Reproduction. 2024;(4):112-120
Acute gyne­cologic pathology in patients with COVID-19. Russian Bulletin of Obstetrician-Gynecologist. 2024;(4):56-62
Psychoemotional state and sexual function in women with chro­nic pelvic pain in geni­tal endo­metriosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):5-15
Psychoemotional health of patients with neuropathic pelvic pain under combined magnetic therapy. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(1):12-18

Chronic pelvic pain syndrome (CPPS) in women is defined as persistent, noncyclic pain perceived to be in structures related to the pelvis and lasting more than six months. Very often no specific etiology can be identified. It is important to exclude other common causes associated with gynecological pathology (endometriosis, pelvic inflammatory disease and/or neuralgia of the pelvic organs and/or with other functional somatic pain syndromes (e.g., irritable bowel syndrome, nonspecific chronic fatigue syndrome) and mental health disorders (e.g., posttraumatic stress disorder, depression). This review provides key recommendations for practice and also considers the risk factors for CPPS, defines a variant of the algorithm for diagnosing this syndrome, the characteristics of pain syndrome and anamnestic data that allow one to suspect genital endometriosis, considers hormonal therapy for pathological conditions such as heavy menstrual bleeding (HMB) and endometriosis, as well as guidelines for the management of women with CPPS.

Keywords:

chronic pelvic pain
dysmenorrhea
abnormal uterine bleeding
hormonal therapy

Authors:

Tapil’skaya N.I.

Saint-Petersburg State Pediatric Medical University

Mironova A.V.

St. Petersburg State Pediatric Medical University of the Ministry of Healthcare of Russian Federation

Silaeva E.A.

Military Medical Academy named after S.M. Kirov of the Ministry of defense of Russian Federation

Shkarupa A.V.

Military Medical Academy named after S.M. Kirov of the Ministry of defense of Russian Federation

Glushakov R.I.

St. Petersburg State Pediatric Medical University of the Ministry of Healthcare of Russian Federation;
Military Medical Academy named after S.M. Kirov of the Ministry of defense of Russian Federation

Received:

18.09.2020

Accepted:

21.11.2020

List of references:

  1. Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, Oberpenning F, de C Williams AC; European Association of Urology. EAU guidelines on chronic pelvic pain. European Urology. 2010;57(1):35-48.  https://doi.org/10.1016/j.eururo.2009.08.020
  2. Adamyan LV, Sonova MM, Arslanyan KN, Loginova ON. Features of chronic pelvic pain in patients with external genital endometriosis. Lechaschiy Vrach. 2019;9:83-87. (In Russ.).
  3. Adamyan LV, Sonova MM, Arslanyan KN, Loginova ON. The role of cytokines in the clinical presentation of external genital endometriosis and chronic pelvic pain. Voprosy ginekologii, akusherstva i perinatologii. 2020;19(1):5-11. (In Russ.). https://doi.org/10.20953/1726-1678-2020-1-5-11
  4. Tapilskaya NI, Karpeev SA, Kuznetsova IV. Subclinical inflammatory diseases of the pelvic organs: chronic endometritis. Ginekologiya. 2014;16(1):104-109. (In Russ.).
  5. American College of Obstetricians and Gynecologists. Chronic Pelvic Pain: ACOG Practice Bulletin. Number 218. Obstetrics and Gynecology. 2020;135(3):98-109.  https://doi.org/10.1097/AOG.0000000000003717
  6. Siqueira-Campos VME, Da Luz RA, de Deus JM, Martinez EZ, Conde DM. Anxiety and depression in women with and without chronic pelvic pain: prevalence and associated factors. Journal of Pain Research. 2019;12:1223-1233. https://doi.org/10.2147/JPR.S195317
  7. Speer L, Mushkbar S, Erbele T. Chronic pelvic pain in women. American Family Physician. 2016;93(5):380-387.  https://doi.org/aafp.org/afp/2008/0601/p1544.html
  8. Urits I, Callan J, Moore WC, Fuller MC, Renschler JS, Fisher P, Jung JW, Hasoon J, Eskander J, Kaye AD, Viswanath O. Cognitive behavioral therapy for the treatment of chronic pelvic pain. Best Practice and Research. Clinical Anaesthesiology. 2020;34(3):409-426.  https://doi.org/10.1016/j.bpa.2020.08.001
  9. Ghai V, Subramanian V, Jan H, Pergialiotis V, Thakar R, Doumouchtsis SK; CHORUS: An International Collaboration for Harmonising Outcomes, Research, Standards in Urogynaecology, Women’s Health. A systematic review on reported outcomes and outcome measures in female idiopathic chronic pelvic pain for the development of a core outcome set. BJOG: An International Journal of Obstetrics and Gynaecology. 2020;10.1111/1471-0528. https://doi.org/10.1111/1471-0528.16412
  10. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. British Medical Journal. 2006;332(7544):749-755.  https://doi.org/10.1136/bmj.38748.697465.55
  11. Teckchandani S, Nagana Gowda GA, Raftery D, Curatolo M. Metabolomics in chronic pain research. European Journal of Pain. 2020; 10.1002/ejp.1677. https://doi.org/10.1002/ejp.1677
  12. Rosen NO, Bergeron S. Genito-pelvic pain through a dyadic lens: moving toward an interpersonal emotion regulation model of women’s sexual dysfunction. Journal of Sex Research. 2019;56(4-5):440-461.  https://doi.org/10.1080/00224499.2018.1513987
  13. Smith SE, Eckert JM. Interventional pain management and female pelvic pain: considerations for diagnosis and treatment. Seminars in Reproductive Medicine. 2018;36(2):159-163.  https://doi.org/10.1055/s-0038-1676104
  14. Li R, Li B, Kreher DA, Benjamin AR, Gubbels A, Smith SM. Association between dysmenorrhea and chronic pain: A systematic review and meta-analysis of population-based studies. American Journal of Obstetrics and Gynecology. 2020;223(3):350-371.  https://doi.org/10.1016/j.ajog.2020.03.002
  15. Aronoff GM. What do we know about the pathophysiology of chronic pain?: implications for treatment considerations. Medical Clinics. 2016;100(1):31-42.  https://doi.org/10.1016/j.mcna.2015.08.004
  16. Stones RW. Chronic pain in women: new perspectives on pathophysiology and management. Reproductive Medicine Review. 2000; 8(3):229-240.  https://doi.org/10.1017/S096227990000034X
  17. Greene SA. Chronic pain: pathophysiology and treatment implications. Topics in Companion Animal Medicine. 2010;25(1):5-9.  https://doi.org/10.1053/j.tcam.2009.10.009
  18. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics and Gynecology. 2006;108 (2):428-441.  https://doi.org/10.1097/01.AOG.0000230214.26638.0c
  19. Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Review of Obstetrics and Gynecology. 2009;4(2):179-189.  https://doi.org/10.1586/17474108.4.2.179
  20. Shapley M, Jordan K, Croft P. Why women consult with increased vaginal bleeding: a case-control study. The British Journal of General Practice. 2002;52(475):108-113. 
  21. Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M, Shahbaazi SH, Abadi A. The relationship between depression and serum ferritin level. European Journal of Clinical Nutrition. 2007; 61(4):532-535.  https://doi.org/10.1038/sj.ejcn.1602542
  22. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry. 2009;65(9):732-741.  https://doi.org/10.1016/j.biopsych.2008.11.029
  23. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455(7215):894-902.  https://doi.org/10.1038/nature07455
  24. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biological Psychiatry. 2010;67(5):446-457.  https://doi.org/10.1016/j.biopsych.2009.09.033
  25. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine. 2009;71(2):171-186.  https://doi.org/10.1097/PSY.0b013e3181907c1b
  26. Singh S, Best C, Dunn S, Leyland N, Wolfman WL; Clinical practice — gynaecology committee. Abnormal uterine bleeding in pre-menopausal women. Journal of Obstetrics and Gynaecology Canada. 2013;35(5):473-475.  https://doi.org/10.1016/S1701-2163(15)30939-7
  27. Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. The Cochrane Database of Systematic Reviews. 2005;4:CD002126. https://doi.org/10.1002/14651858.CD002126.pub3
  28. Farquhar C, Brown J. Oral contraceptive pill for heavy menstrual bleeding. The Cochrane Database of Systematic Reviews. 2009;4: CD000154. https://doi.org/10.1002/14651858.CD000154.pub2
  29. Chernukha GE, Nemova YuI. Diagnostics and pharmacotherapy of abnormal uterine bleeding in light of international treatment guidelines. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie. 2013;2:12-17. (In Russ.).
  30. Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: A randomized clinical trial. Contraception. 2011;83(1):48-54.  https://doi.org/10.1016/j.contraception.2010.06.011
  31. Sayed GH, Zakherah MS, El-Nashar SA, Shaaban MM. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. International Journal of Gynaecology and Obstetrics. 2011;112(2):126-130.  https://doi.org/10.1016/j.ijgo.2010.08.009
  32. Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, Eder SE, Attia GR, Patrick DL, Rubin A, Shangold GA. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstetrics and Gynecology. 2010; 116(4):865-875.  https://doi.org/10.1097/AOG.0b013e3181f20177
  33. Fraser IS, Römer T, Parke S, Zeun S, Mellinger U, Machlitt A, Jensen JT. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial. Human Reproduction. 2011;26(10):2698-2708. https://doi.org/10.1093/humrep/der224
  34. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstetrics and Gynecology. 2011;117(4):777-787.  https://doi.org/10.1097/AOG.0b013e3182118ac3
  35. Dovletkhanova ER, Prilepskaya VN. Estradiol valerate and dienogest in hormonal contraception. Acceptability and effectiveness in real clinical practice. Medicinskij sovet. 2018;13:34-38. (In Russ.). https://doi.org/10.21518/2079-701X-2018-13-34-38
  36. Engeler DS, Baranowski AP, Dinis-Oliveira P, Elneil S, Hughes J, Messelink EJ, van Ophoven A, Williams AC; European Association of Urology. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. European Urology. 2013;3:431-439.  https://doi.org/10.1016/j.eururo.2013.04.035
  37. Naveed M, Muhammad S, Awais I, Asghar A, Hina R Ali M, Muhammad S, Zubair HM, Mirza B, Qi-Gang Z. Therapeutic interventions to urologic chronic pelvic pain syndrome and UPOINT system for clinical phenotyping: How far are we? OSF Preprints. 2020. https://doi.org/10.31219/osf.io/g2evs
  38. Maddern J, Grundy L, Castro J, Brierley SM. Pain in Endometriosis. Frontiers in Cellular Neuroscience. 2020;14:590823. https://doi.org/10.3389/fncel.2020.590823
  39. Tapilskaya NI. Chronic pelvic pain syndrome associated with herpes-viral infection as an interdisciplinary problem. Consilium Medicum. 2014:16(6):24-28. (In Russ.).
  40. Kuznetsov L, Dworzynski K, Davies M, Overton C; Guideline Committee. Diagnosis and management of endometriosis: summary of NICE guidance. British Medical Journal. 2017;358:j3935. https://doi.org/10.1136/bmj.j3935
  41. Barbieri RL. Why are there delays in the diagnosis of endometriosis? OBG Management. 2017;29(3):8-11. 
  42. Bungum HF, Vestergaard C, Knudsen UB. Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic review. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2014;179:209-215.  https://doi.org/10.1016/j.ejogrb.2014.04.025
  43. Boneva RS, Lin J-MS, Unger ER. Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women. Menopause (NY). 2015;22(8):826-834.  https://doi.org/10.1097/GME.0000000000000411
  44. Vercellini P, Fedele L, Aimi G, De Giorgi O, Consonni D, Crosignani PG. Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Human Reproduction. 2006;21(10):2679-2685. https://doi.org/10.1093/humrep/del230
  45. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nature Reviews. Endocrinology. 2019;15(11):666-682.  https://doi.org/10.1038/s41574-019-0245-z
  46. Murji A, Biberoğlu K, Leng J, Mueller MD, Römer T, Vignali M, Yarmolinskaya M. Use of dienogest in endometriosis: a narrative literature review and expert commentary. Current Medical Research and Opinion. 2020;36(5):895-907.  https://doi.org/10.1080/03007995.2020.1744120
  47. Techatraisak K, Hestiantoro A, Ruey S, Banal-Silao MJ, Kim MR, Seong SJ, Thaufik S, Ahlers C, Shin SY, Lee BS. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. BMC Women’s Health. 2019; 19(1):68.  https://doi.org/10.1186/s12905019-0758-6
  48. Engeler D, Baranowski AP, Berghmans B, Borovicka J, Cottrell AM, Dinis-Oliveira P, Elneil S, Hughes J, Messelink EJ, de C Williams AC, Pacheco-Figueiredo L, Parsons B, Goonewardene S, Zumstein V. Guidelines on chronic pelvic pain. European Association of Urology. 2020. Accessed June 20, 2020. https://uroweb.org/guideline/chronic-pelvic-pain
  49. Haugstad GK, Kirste U, Leganger S, Haakonsen E, Haugstad TS. Somatocognitive therapy in the management of chronic gynaecological pain. A review of the historical background and results of a current approach. Scandinavian Journal of Pain. 2018;2(3):124-129.  https://doi.org/10.1016/j.sjpain.2011.02.005
  50. Chronic Pelvic Pain, Initial Management (Green-top Guideline No. 41). Royal College of Obstetricians and Gynaecologists. Accessed June 20, 2020. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg41/
  51. Jacobson TZ, Duffy JM, Barlow D, Koninckx PR, Garry R. Laparoscopic surgery for pelvic pain associated with endometriosis. The Cochrane Database of Systematic Reviews. 2009;4:CD001300. https://doi.org/10.1002/14651858.CD001300.pub2
  52. Cheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain. The Cochrane Database of Systematic Reviews. 2014;3:CD008797. https://doi.org/10.1002/14651858.CD008797.pub2
  53. Yosef A, Allaire C, Williams C, Ahmed AG, Al-Hussaini T, Abdellah MS, Wong F, Lisonkova S, Yong PJ. Multifactorial contributors to the severity of chronic pelvic pain in women. American Journal of Obstetrics and Gynecology. 2016;215(6):760.e1-760.e14.  https://doi.org/10.1016/j.ajog.2016.07.023
  54. Cagnacci A, Della Vecchia E, Xholli A. Chronic pelvic pain improvement: impact on quality of life and mood. Gynecological Endocrinology. 2019;35(6):502-505.  https://doi.org/10.1080/09513590.2018.1540571

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.